Page 2 - Mitchell Kronenberg News Today

Cells in the gut send secret messages to the immune system. Thanks to new research from La Jolla Institute for Immunology (LJI) scientists, we can finally get a look at what they're saying.

If you've ever struggled to breathe, you've had a moment of hypoxia-;a lack of oxygen. Hypoxia can have long-term effects. In fact, doctors describe hypoxia as an "initial insult."

It's not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started showing adverse side effects during a cancer immunotherapy trial, researchers at La Jolla Institute for Immunology (LJI) Center for Cancer Immunotherapy and University of Liverpool went back through the data and worked with patient samples to see what went wrong.

Bill Oxford/iStock(NEW YORK) -- For Mitchell Kronenberg, answers on the Johnson & Johnson vaccine can't come soon enough. A 42-year-old dad living outside Charlotte, North Carolina, Kronenberg enrolled in a clinical trial for the single-dose vaccine and got his shot last January. Since then, he's been patiently waiting for U.S. federal regulators to tell him what to do next to stay safe: Should he get another Johnson & Johnson shot? Switch to Moderna or Pfizer? Is his single-s...

WBAL Radio 1090 AM - Relief, eager anticipation for many Americans ahead of FDA decision on booster shots

With an FDA decision on boosters expected as early as Wednesday, people waiting on a final recommendation respond with relief, eager anticipation.

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications News provided by Share this article Share this article LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HS...

Print Erica Ollmann Saphire, a biologist known internationally for her efforts to fight such deadly viruses as COVID-19 and Ebola, has been named president and chief executive officer of the La Jolla Institute, one of the country’s foremost private biomedical research centers. Saphire, 49, will succeed Mitchell Kronenberg, who has led LJI for nearly 20 years. He will remain as chief scientific officer. She will continue to run her lab, which serves as a global clearinghouse in the search for ...

Erica Ollmann Saphire appointed president and CEO of La Jolla Institute for Immunology Dr. Erica Ollmann Saphire Dr. Saphire will become La Jolla Institute’s fifth president when she formally begins her term on September 1, 2021. She will succeed current LJI President Mitchell Kronenberg, who has successfully led the organization for the past 18 years. “I am deeply honored to be asked to carry La Jolla Institute forward and lead such an exceptional group of immunologists and staff,” said ...

A gift from John and Susan Major will fund construction of a new clinical center at the La Jolla Institute for Immunology. Rendering courtesy of La Jolla Institute for Immunology. The La Jolla Institute for Immunology has announced plans for new construction after receiving a gift from John Major, chairman emeritus of the institute’s board of directors, and his wife, Susan. The La Jolla Institute (LJI) announced the gift on Dec. 28. Financial terms were undisclosed. Funds will...